Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee
Status:
Completed
Trial end date:
2020-03-09
Target enrollment:
Participant gender:
Summary
This is an open-label study assessing the effect of the administration of a single
intra-articular (IA) injection of FX006 32 mg on synovial volume in patients with
osteoarthritis (OA) of the knee.